Literature DB >> 1709134

The linkage of Hb Valletta [alpha 2 beta 287(f3)Thr----Pro] and Hb F-Malta-I [alpha 2G gamma 2117(G19)His----Arg] in the Maltese population.

F Kutlar1, A E Felice, J L Grech, W H Bannister, A Kutlar, J B Wilson, B B Webber, H Y Hu, T H Huisman.   

Abstract

We have identified a new stable abnormal hemoglobin called Hb Valletta, which is characterized by a Thr----Pro substitution at position 87 of the beta chain. This mutation was found to be linked to that of the gamma chain variant Hb F-Malta-I with a His----Arg mutation at position 117 of the G gamma chain. Both variants were detected in the blood samples of 34 Maltese and two Italian newborn babies with isoelectrofocusing and reversed phase high performance liquid chromatography. Similar analyses of cord blood from 388 additional Maltese newborns failed to identify either one of these two variants. Additional analyses of 353 Maltese adults (including 39 beta-thalassemia heterozygotes) resulted in the detection of two adult Hb Valletta heterozygotes. Dot-blot hybridization analyses of amplified DNA with a probe specific for the G gamma-F-Malta-I variant showed that both also carried that mutation. These results show close linkage of the mutant forms of the G gamma- and beta-globin genes, 27-28 kb apart, and a failure to identify chromosomes with either the Hb F-Malta-I mutation alone or with the Hb Valletta mutation alone, indicating a low recombination frequency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709134     DOI: 10.1007/bf00201546

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  IHIC variants list. International Hemoglobin Information Center.

Authors: 
Journal:  Hemoglobin       Date:  1989       Impact factor: 0.849

2.  Haemoglobin Camperdown beta104(G6) arginine leads to serine.

Authors:  T Wilkinson; C G Chua; R W Carrell; H Robin; T Exner; K M Lee; H Kronenberg
Journal:  Biochim Biophys Acta       Date:  1975-05-30

3.  Hemoglobin St Luke's, or alpha 2 , 95 Arg (G2) beta 2 .

Authors:  W H Bannister; J L Grech; C F Plese; L L Smith; B P Barton; J B Wilson; C A Reynolds; T H Huisman
Journal:  Eur J Biochem       Date:  1972-09-18

4.  Separation of tryptic peptides of normal and abnormal alpha, beta, gamma, and delta hemoglobin chains by high-performance liquid chromatography.

Authors:  J B Wilson; H Lam; P Pravatmuang; T H Huisman
Journal:  J Chromatogr       Date:  1979-11-21

Review 5.  Separation of hemoglobins and hemoglobin chains by high-performance liquid chromatography.

Authors:  T H Huisman
Journal:  J Chromatogr       Date:  1987-07-17

6.  Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster.

Authors:  S E Antonarakis; C D Boehm; P J Giardina; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Detection of a novel DNA polymorphism in the beta-globin gene cluster.

Authors:  G L Semenza; P Malladi; S Surrey; K Delgrosso; M Poncz; E Schwartz
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

8.  Molecular characterization of beta-globin gene mutations in Malay patients with Hb E-beta-thalassaemia and thalassaemia major.

Authors:  K G Yang; F Kutlar; E George; J B Wilson; A Kutlar; T A Stoming; J M Gonzalez-Redondo; T H Huisman
Journal:  Br J Haematol       Date:  1989-05       Impact factor: 6.998

9.  Hb Marseille [alpha 2 beta 2 N methionyl-2 (NA2) His----Pro]: a new beta chain variant having an extended N-terminus.

Authors:  Y Blouquit; N Arous; D Lena; J Delanoe-Garin; C Lacombe; J Bardakdjian; L Vovan; A Orsini; J Rosa; F Galacteros
Journal:  FEBS Lett       Date:  1984-12-10       Impact factor: 4.124

10.  Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States.

Authors:  J M Gonzalez-Redondo; T A Stoming; K D Lanclos; Y C Gu; A Kutlar; F Kutlar; T Nakatsuji; B Deng; I S Han; V C McKie
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.